Adding MS Detection to the Analysis of Small Biotherapeutics Using Waters ACQUITY QDa Detector

Expanding the body of knowledge surrounding pharmaceutical products is encouraged to identify opportunities for improvement. This is often enhanced by implementing new technologies, such as improved MS instrumentation. This application note describes how the AQUITY QDa Detector can be integrated into workflows for enhanced assay performance and improved productivity in the monitoring of critical quality attributes associated with biotherapeutics such as monoclonal antibodies.